These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 3498681)

  • 1. Genetic markers in patients with intracranial aneurysms.
    Norrgård O; Beckman G; Beckman L; Cedergren B; Fodstad H; Angquist KA
    Hum Hered; 1987; 37(4):255-9. PubMed ID: 3498681
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HLA antigens and complement types in patients with intracranial saccular aneurysms.
    Ostergaard JR; Bruun-Petersen G; Lamm LU
    Tissue Antigens; 1986 Sep; 28(3):176-81. PubMed ID: 3641480
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HLA antigens, blood groups and serum protein groups in patients with intermittent claudication.
    Norrgård O; Beckman G; Cedergren B
    Hum Hered; 1989; 39(4):192-5. PubMed ID: 2583730
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blood groups and HLA antigens in patients with abdominal aortic aneurysms.
    Norrgård O; Cedergren B; Angquist KA; Beckman L
    Hum Hered; 1984; 34(1):9-13. PubMed ID: 6429031
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombination between HLA-A and C and between HLA-B and complement locus C4 in the same individual.
    Thomsen M; Cambon-Thomsen A; Abbal M; Calot M; Arnaud J; Ohayon E
    Tissue Antigens; 1985 Feb; 25(2):75-8. PubMed ID: 3158099
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transferrin C subtypes and occupational photodermatosis of the face.
    Beckman L; Beckman G; Cedergren B; Göransson K; Hallqvist EB; Sikström C
    Hum Hered; 1985; 35(2):89-94. PubMed ID: 3157637
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Polymorphism of C4 and factor B in type I diabetes].
    Blickle JF; Hauptmann G; Goetz J; Tongio MM; Mayer S; Brogard JM; Dorner M
    Pathol Biol (Paris); 1988 Jun; 36(6):791-4. PubMed ID: 3047638
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunogenetic markers as prognostic features in patients from Kentucky with IgA nephropathy.
    Wyatt RJ; Julian BA; Woodford SY; McLean RH; Thompson JS
    Semin Nephrol; 1987 Dec; 7(4):389-92. PubMed ID: 3502194
    [No Abstract]   [Full Text] [Related]  

  • 9. HLA antigens in patients with otosclerosis.
    Dahlqvist A; Diamant H; Dahlqvist SR; Cedergren B
    Acta Otolaryngol; 1985; 100(1-2):33-5. PubMed ID: 3861067
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Class III alleles and high-risk MHC haplotypes in type I diabetes mellitus, Graves' disease and Hashimoto's thyroiditis.
    Skanes VM; Barnard J; Farid N; Marshall WH; Murphy L; Rideout D; Taylor R; Xidos G; Larsen B
    Mol Biol Med; 1986 Apr; 3(2):143-57. PubMed ID: 3461234
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies of HLA, factor B (Bf), complement C2 and C4 haplotypes in type 1 diabetic and control families from northern Sweden.
    Hägglöf B; Holmgren G; Holmlund G; Lindblom B; Olaisen B; Teisberg P
    Hum Hered; 1986; 36(4):201-12. PubMed ID: 3639057
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Complement markers Bf and C4 in multiple sclerosis].
    Fauchet R; Madigand M; Gueguen-Duchesne MY; Papin J; Sabouraud O; Genetet B
    Rev Neurol (Paris); 1984; 140(6-7):422-5. PubMed ID: 6611572
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HLA antigens and Bf allotypes in lichen sclerosus et atrophicus.
    Holt PJ; Darke C
    Tissue Antigens; 1983 Jul; 22(1):89-91. PubMed ID: 6554993
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polymorphism of the fourth component of complement in Graves' disease and type I diabetes mellitus.
    Skanes V; Larsen B; Sampson-Murphy L; Farid NR
    Clin Invest Med; 1985; 8(2):126-32. PubMed ID: 3869086
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HLA and complement genetic markers in diabetic retinopathy.
    McCann VJ; McCluskey J; Kay PH; Zilko PJ; Christiansen FT; Dawkins RL
    Diabetologia; 1983 Mar; 24(3):221. PubMed ID: 6404683
    [No Abstract]   [Full Text] [Related]  

  • 16. Association of HLA-B40 and DRW9 with Japanese alcoholic liver cirrhosis.
    Miyamoto K; Ishii H; Takata H; Takagi S; Shigeta Y; Sekiguchi S; Suyama K; Kohno H; Tsuchiya M
    Pharmacol Biochem Behav; 1983; 18 Suppl 1():467-71. PubMed ID: 6415674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA polymorphism of human HLA-linked complement C4 allotypes, including C4 null alleles, in the Finnish population.
    Partanen J; Peltonen L; Koskimies S; Carroll MC
    Hum Hered; 1987; 37(4):241-9. PubMed ID: 2888726
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HLA antigens and intracranial aneurysms.
    Ryba M; Grieb P; Podobińska I; Iwańska K; Pastuszko M; Górski A
    Acta Neurochir (Wien); 1992; 116(1):1-5. PubMed ID: 1615764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced C4 in HLA-B8 positive patients with Graves' disease.
    Tom W; Farid NR
    Hum Hered; 1981; 31(4):227-31. PubMed ID: 6895210
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HLA-typing in a family with six intracranial aneurysms.
    Mellergård P; Ljunggren B; Brandt L; Johnson U; Holtås S
    Br J Neurosurg; 1989; 3(4):479-85. PubMed ID: 2803595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.